Suppr超能文献

持续性与非持续性心房颤动的临床特征、管理及控制:来自RealiseAF调查的见解

Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey.

作者信息

Murin Jan, Naditch-Brûlé Lisa, Brette Sandrine, Chiang Chern-En, O'Neill James, Steg P Gabriel

机构信息

Department of Internal Medicine and Cardiology, Comenius University, Bratislava, Slovakia.

Global Strategic Unit Cardio-Thrombosis, Sanofi, Paris, France.

出版信息

PLoS One. 2014 Jan 31;9(1):e86443. doi: 10.1371/journal.pone.0086443. eCollection 2014.

Abstract

BACKGROUND

Atrial fibrillation can be categorized into nonpermanent and permanent atrial fibrillation. There is less information on permanent than on nonpermanent atrial fibrillation patients. This analysis aimed to describe the characteristics and current management, including the proportion of patients with successful atrial fibrillation control, of these atrial fibrillation subsets in a large, geographically diverse contemporary sample.

METHODS AND RESULTS

Data from RealiseAF, an international, observational, cross-sectional survey of 10,491 patients with atrial fibrillation, were used to characterize permanent atrial fibrillation (N = 4869) and nonpermanent atrial fibrillation (N = 5622) patients. Permanent atrial fibrillation patients were older, had a longer time since atrial fibrillation diagnosis, a higher symptom burden, and were more likely to be physically inactive. They also had a higher mean (SD) CHADS2 score (2.2 [1.3] vs. 1.7 [1.3], p<0.001), and a higher frequency of CHADS2 score ≥2 (67.3% vs. 53.0%, p<0.001) and comorbidities, most notably heart failure. Physicians indicated using a rate-control strategy in 84.2% of permanent atrial fibrillation patients (vs. 27.5% in nonpermanent atrial fibrillation). Only 50.2% (N = 2262/4508) of permanent atrial fibrillation patients were controlled. These patients had a longer time since atrial fibrillation diagnosis, a lower symptom burden, less obesity and physical inactivity, less severe heart failure, and fewer hospitalizations for acute heart failure than uncontrolled permanent atrial fibrillation patients, but with more arrhythmic events. The most frequent causes of hospitalization in the last 12 months were acute heart failure and stroke.

CONCLUSION

Permanent atrial fibrillation is a high-risk subset of atrial fibrillation, representing half of all atrial fibrillation patients, yet rate control is only achieved in around half. Since control is associated with lower symptom burden and heart failure, adequate rate control is an important target for improving the management of permanent atrial fibrillation patients.

摘要

背景

心房颤动可分为非永久性和永久性心房颤动。关于永久性心房颤动患者的信息比非永久性心房颤动患者少。本分析旨在描述在一个地域广泛的当代大型样本中,这些心房颤动亚组的特征和当前管理情况,包括心房颤动得到成功控制的患者比例。

方法和结果

来自RealiseAF的数据,这是一项对10491例心房颤动患者进行的国际观察性横断面调查,用于描述永久性心房颤动(N = 4869)和非永久性心房颤动(N = 5622)患者的特征。永久性心房颤动患者年龄更大,自心房颤动诊断以来的时间更长,症状负担更重,且身体活动较少的可能性更大。他们的平均(标准差)CHADS2评分也更高(2.2 [1.3] 对1.7 [1.3],p<0.001),CHADS2评分≥2的频率更高(67.3%对53.0%,p<0.001),合并症更多,最显著的是心力衰竭。医生表示在84.2%的永久性心房颤动患者中采用心率控制策略(非永久性心房颤动患者中为27.5%)。只有50.2%(N = 2262/4508)的永久性心房颤动患者得到了控制。与未得到控制的永久性心房颤动患者相比,这些患者自心房颤动诊断以来的时间更长,症状负担更低,肥胖和身体活动少的情况更少,心力衰竭不太严重,急性心力衰竭住院次数更少,但心律失常事件更多。过去12个月中最常见的住院原因是急性心力衰竭和中风。

结论

永久性心房颤动是心房颤动的一个高危亚组,占所有心房颤动患者的一半,但心率控制仅在大约一半的患者中实现。由于控制与较低的症状负担和心力衰竭相关,充分的心率控制是改善永久性心房颤动患者管理的一个重要目标。

相似文献

5
Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure.
J Heart Lung Transplant. 2000 Jul;19(7):638-43. doi: 10.1016/s1053-2498(00)00123-6.
10
Rate control in atrial fibrillation.
Lancet. 2016 Aug 20;388(10046):818-28. doi: 10.1016/S0140-6736(16)31258-2.

引用本文的文献

1
Atrial Fibrillation Symptoms and Sex, Race, and Psychological Distress: A Literature Review.
J Cardiovasc Nurs. 2018 Mar/Apr;33(2):137-143. doi: 10.1097/JCN.0000000000000421.
2
Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.
J Pharmacol Exp Ther. 2016 Sep;358(3):441-9. doi: 10.1124/jpet.116.234591. Epub 2016 Jun 27.
3
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.
Nat Rev Cardiol. 2016 Jun;13(6):321-32. doi: 10.1038/nrcardio.2016.45. Epub 2016 Apr 7.

本文引用的文献

2
Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
Eur Heart J. 2013 May;34(20):1481-8. doi: 10.1093/eurheartj/ehs348. Epub 2012 Nov 27.
3
Medical treatment of atrial fibrillation.
J Cardiovasc Med (Hagerstown). 2012 Feb;13(2):97-107. doi: 10.2459/JCM.0b013e32834f23e1.
5
Dronedarone in high-risk permanent atrial fibrillation.
N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14.
6
Patients with atrial fibrillation in a primary care setting: Val-FAAP study.
Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):47-53. doi: 10.1016/j.recesp.2011.08.008. Epub 2011 Nov 4.
10
Characteristics and management of outpatients with history of or current atrial fibrillation: the observational French EPHA study.
Arch Cardiovasc Dis. 2010 Jun-Jul;103(6-7):376-87. doi: 10.1016/j.acvd.2010.06.001. Epub 2010 Jul 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验